Ignite Creation Date:
2025-12-24 @ 2:09 PM
Ignite Modification Date:
2026-06-29 @ 10:52 PM
Study NCT ID:
NCT03893695
Status:
COMPLETED
Last Update Posted:
2024-02-09
First Post:
2019-03-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of GT90001 and Nivolumab in Patients With Metastatic Hepatocellular Carcinoma(HCC)
Sponsor:
Suzhou Kintor Pharmaceutical Inc,
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GT90001-TW-1001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None